Observational Study on Genetic Mechanisms in Human Lung Disease
This observational study aims to evaluate genetic mechanisms underlying lung diseases by surveying polymorphic genes involved in respiratory function and examining gene expression in lung cells of individuals with pulmonary diseases. It includes a large cohort of 3500 participants and has a follow-up period of one year to analyze hereditary factors related to lung health.
- Tags
- #Other
- Most relevant to
- —
- Source
- Read original source
- Human efficacy
- Not yet assessed
- Mechanism
- Not yet assessed
- Evidence strength
- Not yet assessed
- Outcome
- Not yet assessed
Why it matters
Understanding genetic mechanisms can provide insights into the factors influencing lung diseases, potentially guiding future research and interventions.
What this does not prove
The study has not published any results yet, and the planned enrollment and endpoints do not constitute findings.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Observational
- Participants / samples
- 3500 · basis not reported
- Randomised
- No
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- Not reported
- Evidence reviewed
- Trial registry record
- Regulatory approval
- No
- Research areas
- Other
Original sources
- Trial registrationRole of Genetic Factors in the Development of Lung Disease ↗
Supporting passages (10)
study design"detailedDescription": "This study is designed to evaluate genetic mechanisms of lung disease by surveying polymorphic genes involved in respiratory function and examining gene expression in the lung cells of individuals with pulmonary disease (e.g., alpha 1-antitrypsin deficiency, asthma, chronic obstructive pulmonary disease, cystic fibrosis, sarcoidosis, history of infection, and genetic mutations consistent with lung pathology).
subjectsAllowing subjects to be included in the study may glean important information about individuals with uncommon pulmonary disease during and post pregnancy.\n\nPatients with abnormalities in ADP-ribosyltransferases, ADP-ribosyl-acceptor hydrolases, and their substrates.
sample size"count": 3500,
randomizedChildren will not be enrolled in the optional CT sub-study unless they have had a standard CT scan for medical purposes to use in comparison.
regulatory approvalChildren will not be enrolled in the optional CT sub-study unless they have had a standard CT scan for medical purposes to use in comparison.
research categories"detailedDescription": "This study is designed to evaluate genetic mechanisms of lung disease by surveying polymorphic genes involved in respiratory function and examining gene expression in the lung cells of individuals with pulmonary disease (e.g., alpha 1-antitrypsin deficiency, asthma, chronic obstructive pulmonary disease, cystic fibrosis, sarcoidosis, history of infection, and genetic mutations consistent with lung pathology).
primary endpoint"measure": "evaluating the role of hereditary factor",
follow up"timeFrame": "1 year"
findings"detailedDescription": "This study is designed to evaluate genetic mechanisms of lung disease by surveying polymorphic genes involved in respiratory function and examining gene expression in the lung cells of individuals with pulmonary disease (e.g., alpha 1-antitrypsin deficiency, asthma, chronic obstructive pulmonary disease, cystic fibrosis, sarcoidosis, history of infection, and genetic mutations consistent with lung pathology).
limitationsNo results are posted. Planned enrolment and endpoints are not findings.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.